beta
PPHM
Peregrine Pharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Peregrine Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It develops novel investigational products that help utilize the immune system to fight cancer, also known as immunotherapy.
Market Cap: 191 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.peregrineinc.com
Shares Outstanding: 45.2 Million
Float: 44 Million
Dividend: 0.0 (0.0%)
Beta: 2.474737
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 968 trading days
From: 2014-03-05 To: 2018-01-05
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-07-10 | 7.0 | 1.0 | 7.0 |